GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, and the GIP/GLP-1 dual agonist tirzepatide, act on appetite regulation, satiety, and gastric emptying
For instance, the HNR-3 technology of hexylresorcinol (HR), niacinamide (VB3), retinyl propionate (RPC) and a retinol booster has been clinically proven to reduce hyperpigmentation in 4 weeks and give you an even skin tone within 8 weeks of application
However, before using, please consider any contraindications, including individual intolerance to any of the ingredients, pregnancy, lactation, and childhood
Stress and poor sleep can add more strain
PDND, Parkinson's disease non-demented
Below is a typical provider-guided tapering structure